Related references
Note: Only part of the references are listed.(Pro)renin Receptor-Mediated Signal Transduction and Tissue Renin-Angiotensin System Contribute to Diabetes-Induced Retinal Inflammation
Shingo Satofuka et al.
DIABETES (2009)
Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species
Yongzhong Wei et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2008)
Characterization of a functional (pro)renin receptor in rat brain neurons
Zhiying Shan et al.
EXPERIMENTAL PHYSIOLOGY (2008)
Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide
Sandra Feldt et al.
HYPERTENSION (2008)
Angiotensin receptor blockers improve insulin resistance in type 2 diabetic rats by modulating adipose tissue
Mi H. Lee et al.
KIDNEY INTERNATIONAL (2008)
Relationship between adipocyte size and adipokine expression and secretion
Thomas Skurk et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Renin receptor expression in human adipose tissue
Vincent Achard et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)
Contribution of nonproteolytically activated prorenin in glomeruli to hypertensive renal damage
Atsuhiro Ichihara et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension
A Ichihara et al.
HYPERTENSION (2006)
Augmentation of intrarenal angiotensin II levels in uninephrectomized aldosterone/salt-treated hypertensive rats; Renoprotective effects of an ultrahigh dose of olmesartan
Yu-Yan Fan et al.
HYPERTENSION RESEARCH (2006)
Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats
Y Nagai et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Human prorenin has gate and handle regions for its non-proteolytic activation
F Suzuki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study
LH Lindholm et al.
JOURNAL OF HYPERTENSION (2002)
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
B Dahlöf et al.
LANCET (2002)
Ramipril and the development of diabetes
S Yusuf et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats
EJ Henriksen et al.
HYPERTENSION (2001)
Effects of cilnidipine on muscle fiber composition, capillary density and muscle blood flow in fructose-fed rats
M Takada et al.
HYPERTENSION RESEARCH (2001)
Cholesterol, a cell size-dependent signal that regulates glucose metabolism and gene expression in adipocytes
S Le Lay et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver
ED Abel et al.
NATURE (2001)
Share Paper
